takeda settles 2 billion 250x140 $2.4 billion settlement agreement reached in Actos bladder cancer litigationTakeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims tied to its Type 2 diabetes drug Actos. The settlement will compensate an anticipated 9,000 claimants who filed federal and state lawsuits alleging they suffered from bladder cancer after taking Actos, says Beasley Allen lawyer Andy D. Birchfield, who is head of the firm’s Mass Torts Section. He serves on the Plaintiffs Steering Committee for the Actos multidistrict litigation (MDL) and was one of the signatories for the settlement agreement.

The settlement follows a record-setting $9 billion jury verdict one year ago in the MDL bellwether case before Judge Rebecca F. Doherty, who is overseeing the consolidated litigation in the United States District Court, Western District of Louisiana. The lead trial lawyer in that case was Mark Lanier from Houston, Texas.

“This is a great settlement for Actos claimants and I am excited that victims will receive good, fair compensation for their injuries,” Birchfield said. “This settlement program has been carefully constructed to fairly compensate claimants based upon the extent of their injuries and their cumulative exposure to Actos, taking into account other risk factors that could have contributed to their injuries. This is a good day for the hundreds of Actos clients represented by Beasley Allen, and we are grateful to have been able to obtain such a positive resolution on their behalf.”

In 2011, the Food and Drug Administration (FDA) issued a safety communication regarding the potential link between Actos and bladder cancer, which the lawsuits claim was seven years after the company first discovered a link between Actos and bladder cancer.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

$2.4 Billion Actos Bladder Cancer Settlement Explained

Beasley Allen principal Frank Woodson discusses the recent $2.4 billion Actos settlement on Ringler...
Federal jury orders drugmakers to pay $9 billion for actos cancer risk

Actos verdict illustrates companies that co-promote...

A federal judge’s decision not to overturn a jury’s $9 billion verdict against Takeda Pharmaceutical...

Actos and its link to bladder cancer discussed by...

Actos, manufactured by Takeda Pharmaceuticals, was issued a warning by the FDA saying people who have...

Actos, TVM and Zohydro litigation discussed by Andy...

Beasley Allen attorneys Andy Birchfield and Leigh O'Dell discuss their progress on litigation involving...
Federal jury orders drugmakers to pay $9 billion for actos cancer risk

Federal jury orders drug makers Takeda, Eli Lilly to...

Jurors found Takeda Pharmaceutical Co. and Eli Lilly & Co. liable for a combined $9 billion in punitive...

Type 2 diabetes drugs may increase risk of pancreatic...

A commonly prescribed class of Type 2 diabetes drugs known as incretin mimetics may put users at risk...

Professional and appropriate manner

My claim was handled in a very professional and appropriate manner. I was very pleased with my outcome and that the claim was resolved without having to go through a trial.

—Michael